What is hepatic multiple hemangioma?
A hepatic multiple hemangioma refers to the presence of two or more benign vascular tumors—hemangiomas—in the liver. Hepatic hemangiomas are the most common benign liver neoplasms in adults, composed of abnormal clusters of blood vessels lined by endothelial cells, embedded within a fibrous stroma. They are typically asymptomatic, discovered incidentally during abdominal imaging (e.g., ultrasound, CT, or MRI) performed for unrelated reasons. While solitary hemangiomas are far more common, “multiple” is generally defined as three or more lesions; however, some clinicians consider two or more as clinically relevant when evaluating distribution, size, and growth patterns.
These lesions are thought to be congenital in origin, arising from developmental anomalies in the hepatic vasculature rather than true neoplasms. They rarely grow after adolescence and almost never undergo malignant transformation. Most remain stable over time, with only a small subset demonstrating slow enlargement—particularly during pregnancy or with exogenous estrogen exposure, due to hormonal influences on vascular endothelium.
Clinically, patients with multiple hepatic hemangiomas are usually asymptomatic unless lesions are very large (>5 cm) or numerous enough to cause mass effect, compress adjacent structures, or lead to consumptive coagulopathy (Kasabach–Merritt phenomenon), though the latter is exceedingly rare in the liver and more typical of large soft-tissue hemangiomas in infants. Symptoms—if present—may include vague right upper quadrant discomfort, early satiety, or hepatomegaly.
Diagnosis relies primarily on cross-sectional imaging: MRI is the most sensitive and specific modality, showing characteristic peripheral nodular enhancement with progressive centripetal fill-in on contrast-enhanced sequences. CT demonstrates similar enhancement dynamics but with lower sensitivity for small or atypical lesions. Biopsy is contraindicated due to risk of hemorrhage and is unnecessary given the high diagnostic accuracy of noninvasive imaging.
Management is overwhelmingly conservative. Asymptomatic multiple hemangiomas—regardless of number—do not require treatment or routine surveillance unless they exceed 5 cm in diameter or demonstrate interval growth on serial imaging. Surgical resection, embolization, or radiofrequency ablation are reserved for rare cases with documented symptoms directly attributable to the lesions, significant growth, or diagnostic uncertainty that cannot be resolved radiologically. Long-term prognosis is excellent, with no impact on life expectancy or liver function in the vast majority of individuals.